| 1 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 49.2% |
| 2 | Leukemia, T-Cell | 36% |
| 3 | Leukemia, B-Cell | 36% |
| 4 | Lymphoma | 26.6% |
| 5 | Leukemia, Large Granular Lymphocytic | 23.8% |
| 6 | Tumor Lysis Syndrome | 22.7% |
| 7 | Autoimmune Lymphoproliferative Syndrome | 18.8% |
| 8 | Sezary Syndrome | 18.4% |
| 9 | Leukemia, Plasma Cell | 17.4% |
| 10 | Infectious Mononucleosis | 17.4% |
| 11 | Composite Lymphoma | 16.6% |
| 12 | Plasmacytoma | 16.2% |
| 13 | Hodgkin Disease | 15.3% |
| 14 | Lymphoma, Non-Hodgkin | 15.3% |
| 15 | Primary amyloidosis | 15.1% |
| 16 | Heavy Chain Disease | 14.3% |
| 17 | Sarcoidosis | 14.1% |
| 18 | Histiocytic Disorders, Malignant | 13.8% |
| 19 | Lymphangioleiomyomatosis | 13.7% |
| 20 | Agammaglobulinemia | 13.4% |
| 21 | Waldenstrom Macroglobulinemia | 12.8% |
| 22 | Multiple Myeloma | 12.8% |
| 23 | Leukemia, Experimental | 12% |
| 24 | Lymphocele | 12% |
| 25 | Granuloma | 11.5% |
| 26 | Adenitis | 11% |
| 27 | Histiocytosis | 11% |
| 28 | Lymphadenitis | 11% |
| 29 | Lymphangitis | 11% |
| 30 | Lymphedema | 11% |
| 31 | Neoplasms, Germ Cell and Embryonal | 11% |
| 32 | Neoplasms, Glandular and Epithelial | 11% |
| 33 | Splenic Diseases | 11% |
| 34 | Thymus Hyperplasia | 11% |
| 35 | Pseudolymphoma | 11% |
| 36 | Lymphadenopathy | 11% |
| 37 | Germ Cell Cancer | 11% |
| 38 | Paraproteinemias | 10.5% |
| 39 | Thymus Neoplasms | 10.5% |
| 40 | Leukemia, Radiation-Induced | 10.4% |
| 41 | Lymphoma, Follicular | 9.8% |
| 42 | T-Cell Lymphoma | 9.8% |
| 43 | Mantle cell lymphoma | 9.8% |
| 44 | Neuroectodermal Tumors | 9.7% |
| 45 | Sarcoma, Myeloid | 9.6% |
| 46 | Lymphatic Abnormalities | 9% |
| 47 | Thymoma | 8.9% |
| 48 | Transfusion Reaction | 8.9% |
| 49 | Hypotensive Transfusion Reaction | 8.9% |
| 50 | Hypergammaglobulinemia | 8.9% |
| 51 | Neoplasms, Neuroepithelial | 8.8% |
| 52 | Gliomatosis cerebri | 8.8% |
| 53 | Leukemia L1210 | 8.4% |
| 54 | Leukemia P388 | 8.4% |
| 55 | Monoclonal Gammopathy of Undetermined Significance | 8.3% |
| 56 | Lymphomatoid Granulomatosis | 8.3% |
| 57 | Lymphangiectasis, Intestinal | 8.1% |
| 58 | Splenic Neoplasms | 7.9% |
| 59 | Carcinosarcoma | 7.7% |
| 60 | Hemangiosarcoma | 7.7% |
| 61 | Malignant histiocytosis | 7.7% |
| 62 | lymphangiosarcoma | 7.7% |
| 63 | Histiocytic sarcoma | 7.7% |
| 64 | Leukemia, Myelomonocytic, Chronic | 7.7% |
| 65 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.7% |
| 66 | Mucocutaneous Lymph Node Syndrome | 7.4% |
| 67 | Meningioma | 7.4% |
| 68 | melanoma | 7.2% |
| 69 | Autoimmune Diseases | 7.2% |
| 70 | Hamartoma | 7.2% |
| 71 | Hypersensitivity | 7.2% |
| 72 | Immunologic Deficiency Syndromes | 7.2% |
| 73 | Neoplasms, Hormone-Dependent | 7.2% |
| 74 | Neoplasms, Multiple Primary | 7.2% |
| 75 | Paraneoplastic Syndromes | 7.2% |
| 76 | Precancerous Conditions | 7.2% |
| 77 | Neoplasms, Second Primary | 7.2% |
| 78 | Immune reconstitution syndrome | 7.2% |
| 79 | Immune Reconstitution Inflammatory Syndrome | 7.2% |
| 80 | Lymphoma, T-Cell, Cutaneous | 7.1% |
| 81 | Lymphoma, AIDS-Related | 7.1% |
| 82 | Enteropathy-Associated T-Cell Lymphoma | 7.1% |
| 83 | Primary Effusion Lymphoma | 7.1% |
| 84 | Sarcoidosis, Pulmonary | 6.8% |
| 85 | Trophoblastic Neoplasms | 6.6% |
| 86 | Carcinoma 256, Walker | 6.5% |
| 87 | Adenoma | 6% |
| 88 | Ameloblastoma | 6% |
| 89 | Angiokeratoma | 6% |
| 90 | Carcinoma | 6% |
| 91 | Chordoma | 6% |
| 92 | Elephantiasis | 6% |
| 93 | Hemangioma | 6% |
| 94 | hemangiopericytoma | 6% |
| 95 | Hypersplenism | 6% |
| 96 | Lymphangioma | 6% |
| 97 | Mesenchymoma | 6% |
| 98 | Nevus | 6% |
| 99 | Teratoma | 6% |
| 100 | Hepatoblastoma | 6% |
| 101 | Mixed Tumor, Mullerian | 6% |
| 102 | Germinoma | 6% |
| 103 | Teratocarcinoma | 6% |
| 104 | Angiofibroma | 6% |
| 105 | Elephantiasis Nostras Verrucosa | 6% |
| 106 | Sarcoma | 6% |
| 107 | Epithelioma | 6% |
| 108 | Hematologic Neoplasms | 6% |
| 109 | Carcinoma, Ehrlich Tumor | 5.9% |
| 110 | Dermoid Cyst | 5.9% |
| 111 | Carcinoma, Lewis Lung | 5.9% |
| 112 | Cyst | 5.8% |
| 113 | Neoplastic Processes | 5.8% |
| 114 | Neoplastic Syndromes, Hereditary | 5.8% |
| 115 | Pregnancy Complications, Neoplastic | 5.8% |
| 116 | Mycosis Fungoides | 5.8% |
| 117 | Lymphomatoid Papulosis | 5.8% |
| 118 | Plasmablastic lymphoma | 5.8% |
| 119 | Basal cell carcinoma | 5.8% |
| 120 | Carcinoma, Papillary | 5.8% |
| 121 | Squamous cell carcinoma | 5.8% |
| 122 | Chondrosarcoma | 5.8% |
| 123 | Craniopharyngioma | 5.8% |
| 124 | Cystadenoma | 5.8% |
| 125 | leiomyosarcoma | 5.8% |
| 126 | liposarcoma | 5.8% |
| 127 | Mesothelioma | 5.8% |
| 128 | synovial sarcoma | 5.8% |
| 129 | Neuroectodermal Tumor, Melanotic | 5.8% |
| 130 | Angiomyolipoma | 5.8% |
| 131 | Clear Cell Sarcoma of Soft Tissue | 5.8% |
| 132 | Alveolar Soft Part Sarcoma | 5.8% |
| 133 | Neuroendocrine Tumors | 5.8% |
| 134 | Carcinoma, Basal Cell | 5.8% |
| 135 | Neoplasms, Experimental | 5.7% |
| 136 | Adenoma, Acidophil | 5.6% |
| 137 | Ganglioneuroma | 5.6% |
| 138 | Glioma | 5.6% |
| 139 | Malignant Glioma | 5.6% |
| 140 | Melanoma, Experimental | 5.4% |
| 141 | Burkitt Lymphoma | 5.4% |
| 142 | Medulloblastoma | 5.3% |
| 143 | Leukemia, Myeloid, Chronic-Phase | 5.1% |
| 144 | Splenic Infarction | 4.9% |
| 145 | Sarcoma, Experimental | 4.9% |
| 146 | Histiocytosis, Langerhans-Cell | 4.9% |
| 147 | Cryoglobulinemia | 4.8% |
| 148 | Multiple Endocrine Neoplasia | 4.8% |
| 149 | Neoplasms, Radiation-Induced | 4.8% |
| 150 | Endometrial Stromal Sarcoma | 4.8% |
| 151 | Cystadenocarcinoma | 4.8% |
| 152 | Fibrosarcoma | 4.8% |
| 153 | Osteosarcoma | 4.8% |
| 154 | Mucoepidermoid Carcinoma | 4.8% |
| 155 | Carcinoid Tumor | 4.8% |
| 156 | Neurilemmoma | 4.8% |
| 157 | Hutchinson's Melanotic Freckle | 4.8% |
| 158 | Melanoma, Amelanotic | 4.8% |
| 159 | Glomerulonephritis, Membranoproliferative | 4.7% |
| 160 | Choriocarcinoma | 4.6% |
| 161 | Carcinoma, Lobular | 4.6% |
| 162 | Thrombocytopenic purpura | 4.5% |
| 163 | Acanthoma | 4.5% |
| 164 | Autoimmune thrombocytopenia | 4.3% |
| 165 | Immune thrombocytopenic purpura | 4.3% |
| 166 | Adenofibroma | 4.3% |
| 167 | Fibroadenoma | 4.3% |
| 168 | Malignant Fibrous Histiocytoma | 4.3% |
| 169 | POEMS Syndrome | 4.2% |
| 170 | Splenic Rupture | 4.2% |
| 171 | Disseminated Intravascular Coagulation | 4.1% |
| 172 | Protein S Deficiency | 4.1% |
| 173 | Bone Marrow Neoplasms | 4.1% |
| 174 | Astrocytoma | 4% |
| 175 | Ependymoma | 4% |
| 176 | oligodendroglioma | 4% |
| 177 | Ganglioglioma | 4% |
| 178 | gliosarcoma | 4% |
| 179 | Anaplastic astrocytoma | 4% |
| 180 | Anaplastic Oligodendroglioma | 4% |
| 181 | Lymphopenia | 3.9% |
| 182 | Retinoblastoma | 3.9% |
| 183 | Paraneoplastic Encephalomyelitis | 3.9% |
| 184 | Nephroblastoma | 3.8% |
| 185 | Mammary Neoplasms, Experimental | 3.8% |
| 186 | Mastocytosis | 3.8% |
| 187 | Transfusion-Related Acute Lung Injury | 3.8% |
| 188 | Bowen's Disease | 3.8% |
| 189 | Paraganglioma | 3.8% |
| 190 | Rhabdomyosarcoma | 3.8% |
| 191 | Giant Cell Tumor of Bone | 3.8% |
| 192 | Tuberous Sclerosis | 3.8% |
| 193 | Abdominal Neoplasms | 3.7% |
| 194 | Anemia | 3.7% |
| 195 | Blood Coagulation Disorders | 3.7% |
| 196 | Blood Platelet Disorders | 3.7% |
| 197 | Bone Marrow Diseases | 3.7% |
| 198 | Erythroplasia | 3.7% |
| 199 | Follicular cyst | 3.7% |
| 200 | Head and Neck Neoplasms | 3.7% |
| 201 | Hemorrhagic Disorders | 3.7% |
| 202 | Immune Complex Diseases | 3.7% |
| 203 | Leukocyte Disorders | 3.7% |
| 204 | Methemoglobinemia | 3.7% |
| 205 | Mucocele | 3.7% |
| 206 | Pancytopenia | 3.7% |
| 207 | Pilonidal Cyst | 3.7% |
| 208 | Polycythemia | 3.7% |
| 209 | Soft Tissue Neoplasms | 3.7% |
| 210 | Sulfhemoglobinemia | 3.7% |
| 211 | Thoracic Neoplasms | 3.7% |
| 212 | Thyroglossal Cyst | 3.7% |
| 213 | Antiphospholipid Syndrome | 3.7% |
| 214 | Synovial Cyst | 3.7% |
| 215 | Thrombophilia | 3.7% |
| 216 | Latex allergy | 3.7% |
| 217 | Erythrocytosis | 3.7% |
| 218 | Aberrant Crypt Foci | 3.7% |
| 219 | Adenocarcinoma | 3.6% |
| 220 | Carcinoma in Situ | 3.6% |
| 221 | Carcinoma, Transitional Cell | 3.6% |
| 222 | Phyllodes Tumor | 3.6% |
| 223 | Dysgerminoma | 3.6% |
| 224 | Hemangioendothelioma | 3.6% |
| 225 | Lipoma | 3.6% |
| 226 | Lymphohistiocytosis, Hemophagocytic | 3.6% |
| 227 | Myoma | 3.6% |
| 228 | Myxoma | 3.6% |
| 229 | Neuroma | 3.6% |
| 230 | Papilloma | 3.6% |
| 231 | Pseudomyxoma Peritonei | 3.6% |
| 232 | Seminoma | 3.6% |
| 233 | Papillomatosis | 3.6% |
| 234 | Angiolipoma | 3.6% |
| 235 | Myelolipoma | 3.6% |
| 236 | Neoplasms, Bone Tissue | 3.6% |
| 237 | Neoplasms, Fibrous Tissue | 3.6% |
| 238 | Smooth Muscle Tumor | 3.6% |
| 239 | Adenomatosis, Pulmonary | 3.6% |
| 240 | Adenomatous Polyps | 3.6% |
| 241 | Carcinoma, Large Cell | 3.6% |
| 242 | Carcinoma, Small Cell | 3.6% |
| 243 | Desmoplastic Small Round Cell Tumor | 3.6% |
| 244 | Schnitzler Syndrome | 3.6% |
| 245 | Erdheim-Chester Disease | 3.6% |
| 246 | Chondroma | 3.6% |
| 247 | Enchondroma | 3.6% |
| 248 | Malignant Carcinoid Syndrome | 3.6% |
| 249 | Sarcoma 180 | 3.5% |
| 250 | Thrombocythemia, Essential | 3.5% |
| 251 | Dermatofibrosarcoma | 3.3% |
| 252 | Dermatofibrosarcoma Protuberans | 3.3% |
| 253 | Neurofibrosarcoma | 3.3% |
| 254 | Hemangioma, Cavernous | 3.2% |
| 255 | Glioblastoma | 3.2% |
| 256 | Neuroblastoma | 3.2% |
| 257 | Glioblastoma Multiforme | 3.2% |
| 258 | Basal Cell Nevus Syndrome | 3.1% |
| 259 | Digestive System Neoplasms | 3.1% |
| 260 | Endocrine Gland Neoplasms | 3.1% |
| 261 | Eye Neoplasms | 3.1% |
| 262 | Nervous System Neoplasms | 3.1% |
| 263 | Environmental Illness | 3.1% |
| 264 | Mesoblastic Nephroma | 3% |
| 265 | Thrombasthenia | 3% |
| 266 | Antithrombin III Deficiency | 3% |
| 267 | Protein C Deficiency | 3% |
| 268 | Bone neoplasms | 3% |
| 269 | Leukoplakia | 3% |
| 270 | Lupus Erythematosus, Systemic | 3% |
| 271 | Pancreatic Cyst | 3% |
| 272 | Pregnancy Complications, Hematologic | 3% |
| 273 | Skin Neoplasms | 3% |
| 274 | Overlap syndrome | 3% |
| 275 | Addison Disease | 3% |
| 276 | Barrett Esophagus | 3% |
| 277 | Breast Cyst | 3% |
| 278 | Actinic keratosis | 3% |
| 279 | Mediastinal Cyst | 3% |
| 280 | Neoplasm Invasiveness | 3% |
| 281 | Neoplasm Metastasis | 3% |
| 282 | Neoplasm Recurrence, Local | 3% |
| 283 | Parovarian Cyst | 3% |
| 284 | Pemphigus | 3% |
| 285 | Pericardial Cyst | 3% |
| 286 | Thymic Cyst | 3% |
| 287 | Carcinogenesis | 3% |
| 288 | Autoimmune thyroiditis | 3% |
| 289 | Myxoid cyst | 3% |
| 290 | Primary Adrenal Insufficiency | 3% |
| 291 | Metastasis | 3% |
| 292 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.9% |
| 293 | Autoimmune hepatitis | 2.9% |
| 294 | Mastocytosis, Systemic | 2.9% |
| 295 | Pheochromocytoma | 2.8% |
| 296 | Alveolar rhabdomyosarcoma | 2.8% |
| 297 | Hepatocellular Adenoma | 2.8% |
| 298 | Ganglioneuroblastoma | 2.8% |
| 299 | Polycythemia Vera | 2.7% |
| 300 | Wiskott-Aldrich Syndrome | 2.7% |
| 301 | Vitamin K Deficiency | 2.7% |
| 302 | Carcinoma, Pancreatic Ductal | 2.7% |
| 303 | Multiple Endocrine Neoplasia Type 1 | 2.6% |
| 304 | Hydrops Fetalis | 2.6% |
| 305 | Carcinoid Heart Disease | 2.6% |
| 306 | Thrombocytosis | 2.6% |
| 307 | Job Syndrome | 2.6% |
| 308 | Kernicterus | 2.6% |
| 309 | Afibrinogenemia | 2.5% |
| 310 | Factor VII Deficiency | 2.5% |
| 311 | Factor X Deficiency | 2.5% |
| 312 | Factor XII Deficiency | 2.5% |
| 313 | Hemophilia A | 2.5% |
| 314 | Activated Protein C Resistance | 2.5% |
| 315 | Factor II deficiency | 2.5% |
| 316 | Factor VIII Deficiency | 2.5% |
| 317 | Factor V deficiency | 2.5% |
| 318 | Factor XI Deficiency | 2.5% |
| 319 | Hypoprothrombinemias | 2.5% |
| 320 | Acoustic Neuroma | 2.5% |
| 321 | Latent Autoimmune Diabetes in Adults | 2.5% |
| 322 | Dermatitis Herpetiformis | 2.5% |
| 323 | Kounis Syndrome | 2.5% |
| 324 | Liver Neoplasms, Experimental | 2.5% |
| 325 | HIV Infections | 2.5% |
| 326 | Sturge-Weber Syndrome | 2.5% |
| 327 | Corpus Luteum Cyst | 2.4% |
| 328 | Ovarian Cysts | 2.4% |
| 329 | Eosinophilic Granuloma | 2.4% |
| 330 | Splenosis | 2.4% |
| 331 | Gastrointestinal Stromal Tumors | 2.4% |
| 332 | Prolactinoma | 2.4% |
| 333 | Growth Hormone-Secreting Pituitary Adenoma | 2.4% |
| 334 | neurofibroma | 2.4% |
| 335 | Hydatidiform Mole | 2.4% |
| 336 | Adenoid Cystic Carcinoma | 2.4% |
| 337 | fibroma | 2.4% |
| 338 | Fibromatosis | 2.4% |
| 339 | Osteoblastoma | 2.4% |
| 340 | Osteoma | 2.4% |
| 341 | Rhabdomyoma | 2.4% |
| 342 | Chondromatosis | 2.4% |
| 343 | Adenocarcinoma, Clear Cell | 2.4% |
| 344 | Cholangiocarcinoma | 2.4% |
| 345 | Cervical Intraepithelial Neoplasia | 2.4% |
| 346 | Hemangioblastoma | 2.4% |
| 347 | Lymphoma, Extranodal NK-T-Cell | 2.4% |
| 348 | Lambert-Eaton Myasthenic Syndrome | 2.4% |
| 349 | Parathyroid Neoplasms | 2.4% |
| 350 | Peritoneal Neoplasms | 2.4% |
| 351 | Thyroid Neoplasm | 2.4% |
| 352 | Thyroid carcinoma | 2.4% |
| 353 | Optic Nerve Glioma | 2.3% |
| 354 | Adenomatous Polyposis Coli | 2.2% |
| 355 | Chronic granulomatous disease | 2.2% |
| 356 | Rheumatoid Arthritis | 2.1% |
| 357 | Choledochal Cyst | 2.1% |
| 358 | Juvenile arthritis | 2.1% |
| 359 | granulosa cell tumor | 2.1% |
| 360 | Carcinoma, Ovarian Epithelial | 2.1% |
| 361 | Graves Disease | 2.1% |
| 362 | Pancreatic Neoplasm | 2.1% |
| 363 | Peutz-Jeghers Syndrome | 2.1% |
| 364 | Anti-Glomerular Basement Membrane Disease | 2.1% |
| 365 | Vipoma | 2.1% |
| 366 | Asthma, Aspirin-Induced | 2% |
| 367 | anaphylaxis | 2% |
| 368 | Anemia, Hemolytic | 2% |
| 369 | Anemia, Macrocytic | 2% |
| 370 | Eosinophilia | 2% |
| 371 | Food Allergy | 2% |
| 372 | Hypoproteinemia | 2% |
| 373 | Leukopenia | 2% |
| 374 | Retroperitoneal Neoplasms | 2% |
| 375 | Thrombocytopenia | 2% |
| 376 | Leukostasis | 2% |
| 377 | MYELODYSPLASTIC SYNDROME | 2% |
| 378 | Anaphylactic shock | 2% |
| 379 | Mastocytoma | 1.9% |
| 380 | Hemoglobinuria, Paroxysmal | 1.9% |
| 381 | Leukemoid Reaction | 1.9% |
| 382 | Tracheal Neoplasms | 1.9% |
| 383 | Leukoplakia, Oral | 1.9% |
| 384 | Paraneoplastic Cerebellar Degeneration | 1.8% |
| 385 | Serum Sickness | 1.8% |
| 386 | Fibromatosis, Aggressive | 1.8% |
| 387 | Fibromatosis, Abdominal | 1.8% |
| 388 | Klatskin Tumor | 1.8% |
| 389 | insulinoma | 1.8% |
| 390 | Purpura, Thrombotic Thrombocytopenic | 1.7% |
| 391 | Respiratory Hypersensitivity | 1.7% |
| 392 | Nasopharyngeal carcinoma | 1.7% |
| 393 | Denys-Drash Syndrome | 1.6% |
| 394 | Anemia, Neonatal | 1.6% |
| 395 | Leukocytosis | 1.6% |
| 396 | Mouth Neoplasms | 1.6% |
| 397 | Pelger-Huet Anomaly | 1.6% |
| 398 | Sick Building Syndrome | 1.6% |
| 399 | Central Nervous System Neoplasms | 1.6% |
| 400 | Pleocytosis | 1.6% |
| 401 | Multiple Chemical Sensitivity | 1.6% |
| 402 | Vascular Neoplasms | 1.6% |
| 403 | Esophageal Neoplasms | 1.6% |
| 404 | Myelitis, Transverse | 1.6% |
| 405 | Anemia, Sickle Cell | 1.6% |
| 406 | Thalassemia | 1.6% |
| 407 | Genital Neoplasms, Female | 1.6% |
| 408 | Pancreatic Pseudocyst | 1.6% |
| 409 | Urticaria | 1.6% |
| 410 | Vasculitis, Leukocytoclastic, Cutaneous | 1.6% |
| 411 | Limbic Encephalitis | 1.6% |
| 412 | HTLV-I Infections | 1.6% |
| 413 | Lymphatic Metastasis | 1.6% |
| 414 | Neoplasms, Unknown Primary | 1.6% |
| 415 | Leukemic Infiltration | 1.6% |
| 416 | Breast Neoplasms, Male | 1.6% |
| 417 | Neoplasm Micrometastasis | 1.6% |
| 418 | Triple Negative Breast Neoplasms | 1.6% |
| 419 | Anemia, Diamond-Blackfan | 1.6% |
| 420 | Adrenocortical carcinoma | 1.6% |
| 421 | Leydig Cell Tumor | 1.5% |
| 422 | Gastrinoma | 1.5% |
| 423 | Glucagonoma | 1.5% |
| 424 | Ataxia Telangiectasia | 1.5% |
| 425 | Testicular Neoplasms | 1.5% |
| 426 | Renal Cell Carcinoma | 1.4% |
| 427 | Papillary Renal Cell Carcinoma | 1.4% |
| 428 | Thyroid Nodule | 1.4% |
| 429 | Adrenal Gland Neoplasms | 1.4% |
| 430 | Gastrointestinal Neoplasms | 1.4% |
| 431 | Genital Neoplasms, Male | 1.4% |
| 432 | Liver neoplasms | 1.4% |
| 433 | Uveal Neoplasms | 1.4% |
| 434 | Myasthenia Gravis | 1.4% |
| 435 | Urologic Neoplasms | 1.4% |
| 436 | Uveomeningoencephalitic Syndrome | 1.4% |
| 437 | Drug Eruptions | 1.4% |
| 438 | Ecchymosis | 1.4% |
| 439 | Petechiae | 1.4% |
| 440 | Purpura | 1.4% |
| 441 | Sebaceous Gland Neoplasms | 1.4% |
| 442 | Spinal Neoplasms | 1.4% |
| 443 | Xeroderma Pigmentosum | 1.4% |
| 444 | Granulomatosis with polyangiitis | 1.3% |
| 445 | Dermatitis, Allergic Contact | 1.3% |
| 446 | HIV Seropositivity | 1.3% |
| 447 | Polycystic Ovary Syndrome | 1.3% |
| 448 | Carcinoma, Endometrioid | 1.3% |
| 449 | Opsoclonus-Myoclonus Syndrome | 1.3% |
| 450 | Dupuytren Contracture | 1.2% |
| 451 | Purpura, Hyperglobulinemic | 1.2% |
| 452 | Urticaria Pigmentosa | 1.2% |
| 453 | Primary Myelofibrosis | 1.2% |
| 454 | Agranulocytosis | 1.2% |
| 455 | Anemia, Megaloblastic | 1.2% |
| 456 | Lymphocytosis | 1.2% |
| 457 | Myelofibrosis | 1.2% |
| 458 | Myeloid Metaplasia | 1.2% |
| 459 | Milk Allergy | 1.2% |
| 460 | Hypoalbuminemia | 1.2% |
| 461 | Wheat Hypersensitivity | 1.2% |
| 462 | Hypereosinophilic syndrome | 1.2% |
| 463 | bone marrow fibrosis | 1.2% |
| 464 | Thrombotic Microangiopathies | 1.2% |
| 465 | Stiff-Person Syndrome | 1.2% |
| 466 | Polyradiculoneuropathy | 1.2% |
| 467 | Polyradiculoneuritis | 1.2% |
| 468 | Acquired Immunodeficiency Syndrome | 1.2% |
| 469 | AIDS related complex | 1.2% |
| 470 | Felty Syndrome | 1.2% |
| 471 | Lupus Nephritis | 1.1% |
| 472 | Hemolytic-Uremic Syndrome | 1.1% |
| 473 | Myasthenia Gravis, Autoimmune, Experimental | 1.1% |
| 474 | Waterhouse-Friderichsen Syndrome | 1.1% |
| 475 | AIDS-Related Opportunistic Infections | 1% |
| 476 | Vasculitis, Central Nervous System | 1% |
| 477 | Sickle Cell Trait | 1% |
| 478 | Dermatitis, Atopic | 1% |
| 479 | ovarian neoplasm | 1% |
| 480 | HIV Wasting Syndrome | 1% |
| 481 | Rheumatoid Vasculitis | 1% |
| 482 | AIDS Dementia Complex | 1% |
| 483 | AIDS-Associated Nephropathy | 1% |
| 484 | Nose Neoplasms | 1% |
| 485 | Meningeal Neoplasms | 1% |
| 486 | Pituitary Adenoma | 0.9% |
| 487 | Pituitary Neoplasms | 0.9% |
| 488 | Lupus Vasculitis, Central Nervous System | 0.9% |
| 489 | Fanconi Anemia | 0.9% |
| 490 | Sicca Syndrome | 0.9% |
| 491 | Sjogren's Syndrome | 0.9% |
| 492 | Palatal Neoplasms | 0.9% |
| 493 | HIV-Associated Lipodystrophy Syndrome | 0.9% |
| 494 | Ear Neoplasms | 0.8% |
| 495 | Eyelid Neoplasms | 0.8% |
| 496 | Lung Neoplasms | 0.8% |
| 497 | Pleural Neoplasms | 0.8% |
| 498 | Eosinophilia-Myalgia Syndrome | 0.8% |
| 499 | Acute Chest Syndrome | 0.8% |
| 500 | Zollinger-Ellison syndrome | 0.8% |
| 501 | Angioedema | 0.8% |
| 502 | Cell Transformation, Viral | 0.8% |
| 503 | Brain Neoplasms | 0.8% |
| 504 | Multiple Sclerosis | 0.8% |
| 505 | Salivary Gland Neoplasms | 0.8% |
| 506 | Shwartzman Phenomenon | 0.8% |
| 507 | Spinal Cord Neoplasms | 0.8% |
| 508 | Tongue Neoplasms | 0.8% |
| 509 | Scurvy | 0.8% |
| 510 | Uterine Neoplasms | 0.8% |
| 511 | Vaginal Neoplasms | 0.8% |
| 512 | Vulvar Neoplasms | 0.8% |
| 513 | Purpura Fulminans | 0.8% |
| 514 | Uterine Cancer | 0.8% |
| 515 | Acute Generalized Exanthematous Pustulosis | 0.8% |
| 516 | Fallopian Tube Neoplasms | 0.8% |
| 517 | Neutropenia | 0.8% |
| 518 | Atypical Hemolytic Uremic Syndrome | 0.8% |
| 519 | Neuromyelitis Optica | 0.7% |
| 520 | Leukoencephalitis, Acute Hemorrhagic | 0.7% |
| 521 | Niemann-Pick Disease, Type C | 0.7% |
| 522 | Pharyngeal Neoplasms | 0.7% |
| 523 | Asthma | 0.7% |
| 524 | Central Nervous System Cysts | 0.7% |
| 525 | Bile Duct Neoplasms | 0.7% |
| 526 | gallbladder neoplasm | 0.7% |
| 527 | Intestinal Neoplasms | 0.7% |
| 528 | Penile Neoplasms | 0.7% |
| 529 | Prostatic Neoplasms | 0.7% |
| 530 | Stomach Neoplasms | 0.7% |
| 531 | Encephalomyelitis, Acute Disseminated | 0.7% |
| 532 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.7% |
| 533 | Erythema Nodosum | 0.7% |
| 534 | Neuritis, Autoimmune, Experimental | 0.7% |
| 535 | Dermatitis, Photoallergic | 0.7% |
| 536 | Pulmonary Eosinophilia | 0.6% |
| 537 | Eosinophilic Pneumonia | 0.6% |
| 538 | Meningeal Carcinomatosis | 0.6% |
| 539 | Anemia, Pernicious | 0.6% |
| 540 | Laryngeal neoplasm | 0.6% |
| 541 | Aspergillosis, Allergic Bronchopulmonary | 0.6% |
| 542 | Guillain-Barre Syndrome | 0.6% |
| 543 | Bladder Neoplasm | 0.6% |
| 544 | Kidney Neoplasm | 0.6% |
| 545 | Ureteral Neoplasms | 0.6% |
| 546 | Urethral Neoplasms | 0.6% |
| 547 | Febrile Neutropenia | 0.6% |
| 548 | Bronchial Neoplasms | 0.5% |
| 549 | Asthma, Exercise-Induced | 0.5% |
| 550 | Status Asthmaticus | 0.5% |
| 551 | Multiple Pulmonary Nodules | 0.5% |
| 552 | Toxic Epidermal Necrolysis | 0.5% |
| 553 | Stevens-Johnson Syndrome | 0.5% |
| 554 | Supratentorial Neoplasms | 0.5% |
| 555 | Multiple Sclerosis, Chronic Progressive | 0.5% |
| 556 | Multiple Sclerosis, Relapsing-Remitting | 0.5% |
| 557 | Endometrial Neoplasms | 0.5% |
| 558 | Pseudoxanthoma Elasticum | 0.5% |
| 559 | Giant Cell Arteritis | 0.5% |
| 560 | Temporal Arteritis | 0.5% |
| 561 | Asthma, Occupational | 0.5% |
| 562 | Farmer's Lung | 0.5% |
| 563 | Angioedemas, Hereditary | 0.5% |
| 564 | Hypopharyngeal Neoplasms | 0.5% |
| 565 | Pleural Effusion, Malignant | 0.5% |
| 566 | Hypopharyngeal Cancer | 0.5% |
| 567 | Hay fever | 0.5% |
| 568 | Rhinitis, Allergic, Perennial | 0.5% |
| 569 | Parotid Neoplasms | 0.5% |
| 570 | Prostatic Neoplasms, Castration-Resistant | 0.5% |
| 571 | Nelson Syndrome | 0.5% |
| 572 | Cecal Neoplasms | 0.4% |
| 573 | Duodenal Neoplasms | 0.4% |
| 574 | Hereditary Angioedema Type III | 0.4% |
| 575 | Hereditary Angioedema Types I and II | 0.4% |
| 576 | Brain Stem Neoplasms | 0.4% |
| 577 | Nasopharyngeal Neoplasms | 0.4% |
| 578 | Colorectal Neoplasms | 0.4% |
| 579 | Tonsillar Neoplasms | 0.3% |
| 580 | Cerebellar Neoplasms | 0.3% |
| 581 | Choroid Plexus Papilloma | 0.3% |
| 582 | Paranasal Sinus Neoplasms | 0.3% |
| 583 | Radicular Cyst | 0.3% |
| 584 | Appendiceal Neoplasms | 0.3% |
| 585 | Colonic Neoplasms | 0.3% |
| 586 | Rectal Neoplasms | 0.3% |
| 587 | Miller Fisher Syndrome | 0.3% |
| 588 | Maxillary Sinus Neoplasms | 0.2% |
| 589 | Anus Neoplasms | 0.2% |
| 590 | Sigmoid Neoplasms | 0.2% |